Breast cancer chemoprevention

by Ivana Sestak, Jack Cuzick
Published 2011-12-01

Need for expanded HPV genotyping for cervical screening

by Jack Cuzick, Cosette Wheeler
Published 2016-12-01

Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.

by Alejandra Castañón, Rebecca Landy, Jack Cuzick, Peter Sasieni
Published 2014-01-01

Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial

by Michael J. Hale, Anthony Howell, Mitch Dowsett, Jack Cuzick, Ivana Sestak
Published 2020-12-01

Consistency of the S5 DNA methylation classifier in formalin‐fixed biopsies versus corresponding exfoliated cells for the detection of pre‐cancerous cervical lesions

by Caroline Reuter, Matthew Preece, Rawinder Banwait, Sabrina Boer, Jack Cuzick, Attila Lorincz, Belinda Nedjai
Published 2021-04-01

Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds

by Chao Wang, Adam R. Brentnall, Jack Cuzick, Elaine F. Harkness, D. Gareth Evans, Susan Astley
Published 2018-06-01

A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies

by Chao Wang, Adam R. Brentnall, Jack Cuzick, Elaine F. Harkness, D. Gareth Evans, Susan Astley
Published 2017-10-01

Outcome measures in clinical trials of treatments for acute severe haemorrhage

by Amy Brenner, Monica Arribas, Jack Cuzick, Vipul Jairath, Simon Stanworth, Katharine Ker, Haleema Shakur-Still, Ian Roberts
Published 2018-10-01

Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru.

by Maribel Almonte, Catterina Ferreccio, Silvana Luciani, Miguel Gonzales, Jose M Delgado, Carlos Santos, Manuel Alvarez, Jack Cuzick, Peter Sasieni
Published 2015-01-01

The Relationship between Body Mass Index and Mammographic Density during a Premenopausal Weight Loss Intervention Study

by Emma C. Atakpa, Adam R. Brentnall, Susan Astley, Jack Cuzick, D. Gareth Evans, Ruth M. L. Warren, Anthony Howell, Michelle Harvie
Published 2021-06-01

HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico

by Jorge Salmerón, Leticia Torres-Ibarra, Xavier Bosch, Jack Cuzick, Attila Lörincz, Cosette M Wheeler, Philip E Castle, Claudia Robles, Eduardo Lazcano-Ponce
Published 2016-03-01

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer

by Richard Buus, Belinda Yeo, Adam R. Brentnall, Marie Klintman, Maggie Chon U. Cheang, Komel Khabra, Ivana Sestak, Qiong Gao, Jack Cuzick, Mitch Dowsett
Published 2018-09-01

A Novel Automated Immunoassay Platform to Evaluate the Association of Adiponectin and Leptin Levels with Breast Cancer Risk

by Debora Macis, Valentina Aristarco, Harriet Johansson, Aliana Guerrieri-Gonzaga, Sara Raimondi, Matteo Lazzeroni, Ivana Sestak, Jack Cuzick, Andrea DeCensi, Bernardo Bonanni, Sara Gandini
Published 2021-06-01

Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features

by Jonathan P. Bestwick, Stephen D. Auger, Anette E. Schrag, Donald G. Grosset, Sofia Kanavou, Gavin Giovannoni, Andrew J. Lees, Jack Cuzick, Alastair J. Noyce
Published 2021-09-01

Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas.

by Elzbieta Stankiewicz, David M Prowse, Mansum Ng, Jack Cuzick, David Mesher, Frances Hiscock, Yong-Jie Lu, Nicholas Watkin, Catherine Corbishley, Wayne Lam, Daniel M Berney
Published 2011-03-01

Performance of the Xpert HPV assay in women attending for cervical screening

by Jack Cuzick, K. Cuschieri, K. Denton, M. Hopkins, M.A. Thorat, C. Wright, H. Cubie, C. Moore, M. Kleeman, J. Austin, L. Ashdown-Barr, K. Hunt, L. Cadman
Published 2015-12-01

Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm

by Jonathan P. Bestwick, Stephen D. Auger, Cristina Simonet, Richard N. Rees, Daniel Rack, Mark Jitlal, Gavin Giovannoni, Andrew J. Lees, Jack Cuzick, Anette E. Schrag, Alastair J. Noyce
Published 2021-04-01

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years

by Adam R. Brentnall, Ruth Warren, Elaine F. Harkness, Susan M. Astley, Julia Wiseman, Jill Fox, Lynne Fox, Mikael Eriksson, Per Hall, Jack Cuzick, D. Gareth Evans, Anthony Howell
Published 2020-09-01

Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study

by D Gareth Evans, Susan Astley, Paula Stavrinos, Elaine Harkness, Louise S Donnelly, Sarah Dawe, Ian Jacob, Michelle Harvie, Jack Cuzick, Adam Brentnall, Mary Wilson, Fiona Harrison, Katherine Payne, Anthony Howell
Published 2016-08-01

Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®

by Richard Buus, Zsolt Szijgyarto, Eugene F. Schuster, Hui Xiao, Ben P. Haynes, Ivana Sestak, Jack Cuzick, Laia Paré, Elia Seguí, Nuria Chic, Aleix Prat, Mitch Dowsett, Maggie Chon U. Cheang
Published 2021-02-01